In summary, our data establish a role for the JNK/MMP-2 pathways in IL-1β-induced alterations of the structure and function of lacrimal gland MECs, suggesting that targeting these pathways could be a viable option to alleviating dry eye disease induced by chronic inflammation, as occurs in Sjogren's syndrome. Here, IL1B is linked to Sjogren syndrome.